Clifford Group’s Thermo Fisher Scientific TMO Stock Holding History

Clifford Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Sell	425 -16	-4%	-$7.68K	0.15%	80
2026 Q1	$217K	Sell	441 -47	-10%	-$25.5K	0.17%	75
2025 Q4	$283K	Sell	488 -9	-2%	-$5.09K	0.22%	59
2025 Q3	$241K	Hold	497	–	–	0.19%	75
2025 Q2	$202K	Sell	497 -20	-4%	-$8.36K	0.17%	83
2025 Q1	$257K	Buy	517 +27	+6%	+$14.6K	0.24%	62
2024 Q4	$255K	Sell	490 -2	-0.4%	-$1.1K	0.19%	66
2024 Q3	$304K	Sell	492 -26	-5%	-$15.4K	0.24%	63
2024 Q2	$286K	Hold	518	–	–	0.23%	62
2024 Q1	$301K	Buy	518 +2	+0.4%	+$1.12K	0.25%	58
2023 Q4	$274K	Sell	516 -32	-6%	-$15.5K	0.25%	62
2023 Q3	$277K	Sell	548 -7	-1%	-$3.73K	0.3%	57
2023 Q2	$290K	Buy	555 +6	+1%	+$3.24K	0.31%	57
2023 Q1	$316K	Hold	549	–	–	0.38%	54
2022 Q4	$302K	Buy	+549	New	+$291K	0.38%	61

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clifford Group's TMO Position: Q2 2026 in Review

Clifford Group reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q2 2026, selling an estimated $7.68K and leaving 425 shares worth $213K. The position accounts for 0.15% of the portfolio, ranked #80.

Clifford Group first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $316K in Q1 2023. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Clifford Group held 425 shares of Thermo Fisher Scientific worth $213K as of Q2 2026.
Clifford Group sold 16 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.68K.
Thermo Fisher Scientific made up 0.15% of Clifford Group's portfolio in Q2 2026, its #80 holding.
Clifford Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Clifford Group's Thermo Fisher Scientific position peaked at $316K in Q1 2023.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Clifford Group's 13F filing for Q2 2026, filed 14 Aug 2026.